文献速递白血病造血干细胞移植与细胞治疗

白血病相关髓系细胞通过汇聚于代谢改变的独特信号支持不同T-ALL亚型

Leukemia-associated myeloid cells support distinct T-ALL subtypes via unique signals converging on metabolic alterations.
PubMed 文献 · Blood · 2026-10-01

该研究探讨白血病相关髓系细胞是否支持T-ALL不同分子亚型及其机制。研究发现髓系细胞通过IL6ST/STAT3信号支持ETP样T-ALL,通过生长因子受体信号支持非ETP样T-ALL,两者均需AKT激活,且髓系清除诱导共同代谢转向氧化磷酸化。联合髓系清除与OxPhos抑制可延长白血病小鼠生存。

要点

  • 髓系细胞通过亚型特异性信号支持ETP样和非ETP样T-ALL存活。
  • 两种亚型均依赖AKT激活,髓系清除后共同转向氧化磷酸化。
  • 联合髓系清除与OxPhos抑制优于单药延长白血病小鼠生存。

核心结论

  • 白血病相关髓系细胞通过亚型特异性信号汇聚于代谢调节共同通路支持T-ALL存活。
  • 髓系细胞丢失诱导的代谢适应提示代偿机制使T-ALL在应激下持续存在。
  • 联合髓系清除与OxPhos抑制可减少小鼠和患者T-ALL细胞存活并延长白血病小鼠生存。

研究设计与样本

  • 研究使用LMO2小鼠模型的ETP样和非ETP样T-ALL亚型,进行体外和体内实验。
  • 对小鼠和人类T-ALL进行转录谱分析和体外试验。

主要发现

  • 髓系细胞在体外和体内支持ETP样和非ETP样T-ALL亚型的存活。
  • IL6ST/STAT3信号支持ETP样T-ALL,生长因子受体信号支持非ETP样T-ALL。
  • 两种亚型均需AKT激活以实现髓系介导的支持。
  • 体内急性髓系清除诱导共同代谢转向氧化磷酸化(OxPhos)。
  • 联合髓系清除与OxPhos抑制比任一单药更延长白血病小鼠生存。

临床怎么用

  • 肿瘤-髓系相互作用及下游代谢重编程可作为T-ALL有前景的治疗靶点。
  • 联合靶向髓系细胞与OxPhos可能改善T-ALL治疗效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although intensified chemotherapy regimens have improved survival of T-cell acute lymphoblastic leukemia (T-ALL) patients, treatment-related toxicities and poor outcomes following relapse highlight the need for alternative therapeutics. Our previous studies showed that leukemia-associated myeloid cells support T-ALL progression, suggesting myeloid cells or associated signals could serve as therapeutic targets. It remains unknown whether leukemia-associated myeloid cells support multiple molecular subtypes of T-ALL, and if so, whether subtype-specific mechanisms are involved. We demonstrate that tumor-associated myeloid cells support survival of both Early T-cell Progenitor (ETP)-like and non-ETP-like T-ALL subtypes from the LMO2 mouse model in vitro and in vivo. Transcriptional profiling and in vitro assays of mouse and human T-ALL reveal that myeloid cells support distinct T-ALL subtypes via different signaling pathways: IL6ST/STAT3 signaling supports ETP-like T-ALL, while growth factor receptor signaling supports non-ETP-like T-ALL. Notably, both subtypes require AKT activation for myeloid-mediated support, and acute myeloid depletion in vivo induces a common metabolic shift towards oxidative phosphorylation (OxPhos). These findings suggest that myeloid cells promote T-ALL survival via subtype-specific signals that converge on a common pathway regulating metabolism. The shared metabolic adaptation to myeloid cell loss suggests a compensatory mechanism enabling T-ALL persistence under stress. Consistent with this possibility, combining myeloid depletion with OxPhos inhibition reduces survival of mouse and patient T-ALL cells and prolongs leukemic mouse survival more than either single treatment. Our data highlight unique and shared mechanisms by which myeloid cells support T-ALL subtypes and implicate tumor-myeloid interactions and downstream metabolic reprogramming as promising therapeutic targets.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Nam S, Tetteh DN, Kappil EM, et al. Leukemia-associated myeloid cells support distinct T-ALL subtypes via unique signals converging on metabolic alterations. Blood. 2026. PMID: 42821740. doi:10.1182/blood.2026033335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。